AQUILA STUDY IN GERMANY - REAL WORLD ADHERENCE AND PERSISTENCE OF SECUKINUMAB TREATMENT IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS - AN INTERIM ANALYSIS

被引：8
|
作者：
Kiltz, Uta [1 ,2 ]
Peterlik, Daniel [3 ]
Winkelmann, Veronika [3 ]
Tony, Hans-Peter [4 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Ruhr Univ, Bochum, Germany
[3] Novartis Pharma GmbH, Clin Res Immunol Hepatol & Dermatol, Nurnberg, Germany
[4] Univ Klin, Med Klin 2, Rheumatol Immunol, Wurzburg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY; DOUBLE-BLIND;
D O I：
10.1136/annrheumdis-2019-eular.435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0705
引用
收藏
页码：1814 / 1815
页数：2
相关论文
共 50 条
  • [31] Secukinumab Immunogenicity in Patients with Psoriatic Arthritis and Ankylosing Spondylitis during a 52-Week Treatment Period
    Deodhar, Atul A.
    Gladman, Dafna D.
    McInnes, Iain B.
    Strand, Vibeke
    Ren, Mengyuan
    Spindeldreher, Sebastian
    Pricop, Luminita
    Porter, Brian
    Safi, Jorge
    Shete, Abhijit
    Bruin, Gerard
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] GETTING THE REAL EXPERIENCE: PATIENTS WITH PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED WITH SECUKINUMAB AT THE ARMY HOSPITAL OF SANTIAGO, CHILE
    Grunholz Gambi, Daniela
    Wainstein Gurovich, Eduardo
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S68 - S68
  • [33] BUDGET IMPACT MODEL OF SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS (AS) AND WITH PSORIATIC ARTHRITIS (PSA) IN ITALY
    Colombo, G. L.
    Di Matteo, S.
    Bruno, G. M.
    Valentino, M. C.
    Oselin, M.
    Roccia, A.
    VALUE IN HEALTH, 2016, 19 (07) : A535 - A535
  • [34] PERSISTENCE OF SECUKINUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS: A REAL-WORLD MULTICENTRIC COHORT OF 409 PATIENTS
    Letarouilly, J. G.
    Flachaire, B.
    Labadie, C.
    Cohen, N.
    Kyheng, M.
    Sellam, J.
    Richette, P.
    Dieude, P.
    Claudepierre, P.
    Fautrel, B.
    Houvenagel, E.
    Nguyen, C. D.
    Guyot, M. H.
    Segaud, N.
    Maury, F.
    Marguerie, L.
    Deprez, X.
    Salmon, J. H.
    Baudens, G.
    Richard, C. Miceli
    Gervais, E.
    Valckenaere, I. Chary
    Lafforgue, P.
    Loeuille, D.
    Richez, C.
    Pham, T.
    Flipo, R. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 765 - 765
  • [35] Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis
    de Avila Machado, Marina Amaral
    de Moura, Cristiano Soares
    Ferre, Felipe
    Bernatsky, Sasha
    Rahme, Elham
    Acurcio, Francisco de Assis
    REVISTA DE SAUDE PUBLICA, 2016, 50
  • [36] The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis
    van de Kerkhof, P. C. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (05) : 879 - 879
  • [37] Secukinumab as a potential trigger of inflammatory bowel disease in ankylosing spondylitis or psoriatic arthritis patients
    Onac, Ioana A.
    Clarke, Benjamin D.
    Tacu, Cristina
    Lloyd, Mark
    Hajela, Vijay
    Batty, Thomas
    Thoroughgood, Jamie
    Smith, Sandra
    Irvine, Hannah
    Hill, Diane
    Baxter, Grace
    Horwood, Natalie
    Mahendrakar, Suma
    Rajak, Rizwan
    Griffith, Sian
    Kiely, Patrick D. W.
    Galloway, James
    RHEUMATOLOGY, 2021, 60 (11) : 5233 - 5238
  • [38] PREDICTION OF LOW DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH SECUKINUMAB IN REAL WORLD - DATA FROM THE GERMAN AQUILA STUDY
    Vodencarevic, A.
    Brandt-Juergens, J.
    Peterlik, D.
    Gmeiner, B.
    Kiltz, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1126 - 1126
  • [39] Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study
    Kiltz, Uta
    Sfikakis, Petros P.
    Gaffney, Karl
    Sator, Paul-Gunther
    von Kiedrowski, Ralph
    Bounas, Andreas
    Gullick, Nicola
    Conrad, Curdin
    Rigopoulos, Dimitris
    Lespessailles, Eric
    Romanelli, Marco
    Ghislain, Pierre-Dominique
    Brandt-Juergens, Jan
    Rashkov, Rasho
    Aassi, Maher
    Orsenigo, Roberto
    Perella, Chiara
    Pournara, Effie
    Gathmann, Sven
    Jagiello, Piotr
    Veit, Justyna
    Augustin, Matthias
    ADVANCES IN THERAPY, 2020, 37 (06) : 2865 - 2883
  • [40] HOW DOES BODY MASS INDEX AFFECT SECUKINUMAB TREATMENT OUTCOMES AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY
    Kiltz, U.
    Brandt-Juergens, J.
    Kastner, P.
    Riechers, E.
    Peterlik, D.
    Budden, C.
    Tony, H. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1500 - 1501
12345